Know Cancer

or
forgot password

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159


N/A
18 Years
N/A
Not Enrolling
Both
Peripheral Stem Cell/Marrow Transplant

Thank you

Trial Information

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159


Inclusion Criteria:



- over age 18

- autologous stem cell/marrow transplant candidate in MM, lymphoma, AMG and testicular

Exclusion Criteria:

- age below 18 years

- sensitive to G-CSF

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Principal Investigator

Meluka Game, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Alberta Health Services

Authority:

Canada: Health Canada

Study ID:

HE-10-0053

NCT ID:

NCT00168168

Start Date:

July 2003

Completion Date:

February 2007

Related Keywords:

  • Peripheral Stem Cell/Marrow Transplant
  • G-CSF
  • Filgrastim
  • Engraftment time
  • Autologus transplant

Name

Location